BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 23006834)

  • 21. Effectiveness of DOT for tuberculosis treatment outcomes: a prospective cohort study in Bangkok, Thailand.
    Okanurak K; Kitayaporn D; Wanarangsikul W; Koompong C
    Int J Tuberc Lung Dis; 2007 Jul; 11(7):762-8. PubMed ID: 17609051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mobile direct observation treatment for tuberculosis patients: a technical feasibility pilot using mobile phones in Nairobi, Kenya.
    Hoffman JA; Cunningham JR; Suleh AJ; Sundsmo A; Dekker D; Vago F; Munly K; Igonya EK; Hunt-Glassman J
    Am J Prev Med; 2010 Jul; 39(1):78-80. PubMed ID: 20537846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment costs of directly observed therapy and traditional therapy for Mycobacterium tuberculosis: a comparative analysis.
    Weis SE; Foresman B; Matty KJ; Brown A; Blais FX; Burgess G; King B; Cook PE; Slocum PC
    Int J Tuberc Lung Dis; 1999 Nov; 3(11):976-84. PubMed ID: 10587319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-comparison of different management policies for tuberculosis patients in Italy. AIPO TB Study Group.
    Migliori GB; Ambrosetti M; Besozzi G; Farris B; Nutini S; Saini L; Casali L; Nardini S; Bugiani M; Neri M; Raviglione MC
    Bull World Health Organ; 1999; 77(6):467-76. PubMed ID: 10427931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Direct costs of pulmonary tuberculosis among patients receiving treatment in Bauchi State, Nigeria.
    Umar NA; Abubakar I; Fordham R; Bachmann M
    Int J Tuberc Lung Dis; 2012 Jun; 16(6):835-40. PubMed ID: 22613686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Directly observed treatment for multidrug-resistant tuberculosis: an economic evaluation in the United States of America and South Africa.
    Wilton P; Smith RD; Coast J; Millar M; Karcher A
    Int J Tuberc Lung Dis; 2001 Dec; 5(12):1137-42. PubMed ID: 11769772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Why do tuberculosis patients default in Tashkent City, Uzbekistan? A qualitative study.
    Hasker E; Khodjikhanov M; Sayfiddinova S; Rasulova G; Yuldashova U; Uzakova G; Butabekov I; Veen J; van der Werf MJ; Lefèvre P
    Int J Tuberc Lung Dis; 2010 Sep; 14(9):1132-9. PubMed ID: 20819258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does directly observed therapy improve tuberculosis treatment? More evidence is needed to guide tuberculosis policy.
    McLaren ZM; Milliken AA; Meyer AJ; Sharp AR
    BMC Infect Dis; 2016 Oct; 16(1):537. PubMed ID: 27716104
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Can guardians supervise TB treatment as well as health workers? A study on adherence during the intensive phase.
    Manders AJ; Banerjee A; van den Borne HW; Harries AD; Kok GJ; Salaniponi FM
    Int J Tuberc Lung Dis; 2001 Sep; 5(9):838-42. PubMed ID: 11573895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Community vs. facility-based directly observed treatment for tuberculosis in Tanzania's Kilimanjaro Region.
    van den Boogaard J; Lyimo R; Irongo CF; Boeree MJ; Schaalma H; Aarnoutse RE; Kibiki GS
    Int J Tuberc Lung Dis; 2009 Dec; 13(12):1524-9. PubMed ID: 19919771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patient and family costs associated with tuberculosis, including multidrug-resistant tuberculosis, in Ecuador.
    Rouzier VA; Oxlade O; Verduga R; Gresely L; Menzies D
    Int J Tuberc Lung Dis; 2010 Oct; 14(10):1316-22. PubMed ID: 20843424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Feasibility of an ingestible sensor-based system for monitoring adherence to tuberculosis therapy.
    Belknap R; Weis S; Brookens A; Au-Yeung KY; Moon G; DiCarlo L; Reves R
    PLoS One; 2013; 8(1):e53373. PubMed ID: 23308203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Directly observed therapy (DOT) is not the entire answer: an operational cohort analysis.
    Mangura B; Napolitano E; Passannante M; Sarrel M; McDonald R; Galanowsky K; Reichman L
    Int J Tuberc Lung Dis; 2002 Aug; 6(8):654-61. PubMed ID: 12150475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sharing the burden of TB/HIV? Costs and financing of public-private partnerships for tuberculosis treatment in South Africa.
    Sinanovic E; Kumaranayake L
    Trop Med Int Health; 2006 Sep; 11(9):1466-74. PubMed ID: 16930269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tuberculosis Treatment Monitoring by Video Directly Observed Therapy in 5 Health Districts, California, USA.
    Garfein RS; Liu L; Cuevas-Mota J; Collins K; Muñoz F; Catanzaro DG; Moser K; Higashi J; Al-Samarrai T; Kriner P; Vaishampayan J; Cepeda J; Bulterys MA; Martin NK; Rios P; Raab F
    Emerg Infect Dis; 2018 Oct; 24(10):1806-1815. PubMed ID: 30226154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modeling the epidemiology and economics of directly observed therapy in Baltimore.
    Chaulk CP; Friedman M; Dunning R
    Int J Tuberc Lung Dis; 2000 Mar; 4(3):201-7. PubMed ID: 10751064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Practice of directly observed treatment (DOT) for tuberculosis in southern Thailand: comparison between different types of DOT observers.
    Pungrassami P; Johnsen SP; Chongsuvivatwong V; Olsen J; Sørensen HT
    Int J Tuberc Lung Dis; 2002 May; 6(5):389-95. PubMed ID: 12019914
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Directly observed therapy of tuberculosis in Brazil: associated determinants and impact on treatment outcome.
    Reis-Santos B; Pellacani-Posses I; Macedo LR; Golub JE; Riley LW; Maciel EL
    Int J Tuberc Lung Dis; 2015 Oct; 19(10):1188-93. PubMed ID: 26459531
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Humiliation or care? A qualitative study of patients' and health professionals' experiences with tuberculosis treatment in Norway.
    Sagbakken M; Bjune GA; Frich JC
    Scand J Caring Sci; 2012 Jun; 26(2):313-23. PubMed ID: 22043979
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.